Serial Assessment of Neurodevelopmental Outcome Following Neonatal Encephalopathy and Therapeutic Hypothermia
- PMID: 40482878
- DOI: 10.1016/j.jpeds.2025.114679
Serial Assessment of Neurodevelopmental Outcome Following Neonatal Encephalopathy and Therapeutic Hypothermia
Abstract
Objective: To compare the neurodevelopmental outcome at 18-24 months, 5-6 years, and 8-10 years of age among children who received therapeutic hypothermia (TH) for neonatal encephalopathy (NE) following perinatal asphyxia.
Study design: A retrospective, multicenter cohort study was performed in children with NE treated with TH at 2 level III neonatal intensive care units between January 2008 and December 2015, with neurodevelopmental testing at 18-24 months (visit 1), 5-6 years (visit 2), and 8-10 years (visit 3). Motor, cognitive, and behavioral scores, derived from standardized neurodevelopmental tests, were converted to Z-scores and compared across the visits using linear mixed modeling.
Results: Seventy-seven children were analyzed. In linear mixed modeling, motor Z-scores decreased nonlinearly throughout the follow-up visits, being lower among children with a lower total IQ at 8-10 years and deep gray matter injury on neonatal brain magnetic resonance imaging. Cognitive Z-scores decreased among children with mammillary body abnormalities on neonatal magnetic resonance imaging, and were significantly lower in children with a lower gestational age and lower socioeconomic status. Z-scores indicating internalizing behavioral problems increased linearly (visit 1: median -0.7, IQR 1.4; visit 2: median -0.5, IQR 1.2; visit 3: median -0.1, IQR 1.5).
Conclusions: Motor, cognitive, and behavioral Z-scores significantly worsened from 2 to 8-10 years among children who received TH for NE, highlighting the importance of long-term developmental surveillance.
Keywords: magnetic resonance imaging; neonatal encephalopathy; neurodevelopmental outcome; perinatal asphyxia.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest F.G. is an expert witness in legal cases of perinatal asphyxia and a co-inventor of 2-iminobiotin for neonatal neuroprotection. He has no financial activities related to the present manuscript to disclose. The other authors have no conflicts of interest to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical